Neudle.com: immune related adverse events

Differential
(Click to cross reference)

abducens nerve paralysis

abortion, spontaneous

abscess, intracerebral

abscess, intracranial-fungal

acetylcholine receptor antibody

aciduria

acoustic nerve

acquired immunodeficiency syndrome

acyclovir

adalimumab

addiction, heroin

advances in neurology

adverse drug reaction

AMPA receptor antibodies

amyloid angiopathy, cerebral

aneurysm, intracranial

aneurysm, intracranial, growth

aneurysm, intracranial, treatment of

aneurysm, multiple intracranial

aneurysm, size

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiography, neurologic complications with

angiotensin-converting enzyme

anti HMGCR antibody

anti JC virus antibodies

antibiotic prophylaxis

antibiotics

anticholinesterase

anticoagulant, reversal of

anticoagulant, treatment

anticonvulsants

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, untoward effects of

antiganglioside antibodies

antimetabolite

antineutrophil cytoplasmic autoantibodies

anti-PF4-heparin IgG antibodies

antistriational muscle antibody

antiviral agents

aphasia

apraxia, constructional

aqueduct of Sylvius, stenosis

arteritis, temporal, recurrent

arthralgia

aspartate aminotransferase

aspergillosis

asthma

ataxia

ataxia telangiectasia

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autoimmune epilepsy

autonomic dysfunction

bacterial infection, CNS

basal cistern

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder, acute

bone marrow suppression

bone marrow transplantation

bortezomib

brachial plexus

brachial plexus injury

brachial plexus neuropathy

bradycardia

bradykinesia

brain biopsy

brain biopsy, complications of

brain biopsy, false negative

brain biopsy, indication

brain biopsy, negative

brain natriuretic peptide

brain transplantation

brain transplantation, complications of

brainstem

brainstem, infarction of

campylobacter infection

cancer associated myopathy

cardiac surgery, neurologic complications with

cardiac transplantation

cardiomyopathy

cardiopulmonary bypass

cardiotoxicity

CAT scan

CAT scan, abnormal

CAT scan, cardiac, ultrafast

CAT scan, chest

CAT scan, contrast enhanced

cataracts

catatonia

cauda equina

cauda equina, enhancement

cauda equina, lesion of

CD19-directed chimeric antigen receptor T-cell therapy

CD4 counts

central nervous system, infection of

central nervous system, infection, cancer patient

central venous catheter

centrum semiovale

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral cortex

cerebral edema

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction

cerebral ischemia

cerebral palsy

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, cell count, normal

cerebrospinal fluid, culture negative

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, leak

cerebrospinal fluid, proteincytologic dissociation

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, delayed onset

cerebrovascular accident, perioperative

cerebrovascular accident, postoperative

cerebrovascular accident, prevention of

cerebrovascular disease

cesarean section

chemical weapons

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

choroid plexus, enhancement

chromosome 4

chronic fatigue syndrome

chronic graft versus host disease

Churg-Strauss syndrome

cladribine

Clinical Pathologic Conference(C.P.C.)

coccidioidomycosis

cognition

coinfection

collagen vascular disease

collapsin response mediator protein 5 IgG

compression neuropathy

concentration, impaired

conduction block

confusion

confusional state, acute

congenital heart disease

congenital malformation

congestive heart failure

controversies in neurology

conversion reaction

cop 1

cortical blindness

cortical blindness, transient

cost

cost effectiveness

cough

cranial nerve palsies

cranial neuropathy

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

critical care unit

cryptococcal antigen

cryptococcal meningitis

cryptococcoma, cerebral

cryptococcosis

cyclophosphamide

cyclosporine

cytokine release syndrome

cytokines

cytomegalovirus infection

dementia, rapidly progressive

dementia, reversible

demyelinating disease

dental procedure, neurologic complications with

dentate nuclei

dentate nuclei, lesion of

dermatomyositis

developmental milestones, loss of

differential diagnosis

dilantin

dilantin, toxicity

diplopia

disability, neurological

disease modifying agents

disorientation

dopa responsive dystonia

DPPX, antibodies, encephalitis

dropped head syndrome

drowsiness

drug abuse

drug holiday

drug induced neurologic disorders

dyskinesia, drug induced

dystonia, drug induced

echocardiogram

echocardiogram, transesophageal

echocardiogram, transesophageal, false negative

electrocardiogram, abnormal

electroencephalogram, abnormalities of

electromyogram

electromyogram, decremental response

embolism

embolism, septic

embolization, therapeutic, coils

emergencies, neurologic

encephalitis

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, etiology

encephalitis, focal

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, acute

encephalopathy, anoxic

encephalopathy, metabolic

endemic area

endocarditis

endocarditis, acute bacterial

endocarditis, infectious

endocarditis, prophylaxis

endocarditis, subacute bacterial

epidemiology of neurology

episodic disorders

Epstein-Barr virus

Epstein-Barr virus, negative

etanercept

evidence-based research

extralimbic encephalitis

eye closure

facial nerve palsy

faciobrachial dystonic seizure

finger nose finger test

fluorescent treponema antibody absorption/false positive

fungal infection, CNS

fungal infection, CNS, treatment of

gabapentin

gadolinium

gag reflex, depressed

gait disorder

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gastrointestinal bleeding

gender

gene

geographic location

glioblastoma multiforme(astrocytoma Gr.III)

glioma

GLUT1 deficiency syndrome

glutamic acid decarboxylase, antibody

GM antigen test

gram positive rod

granuloma, eosinophilic

granulomatous disease

granulomatous hypophysitis

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, axonal form

Guillain Barre syndrome, complications

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, infantile and childhood form

Guillain Barre syndrome, prognosis of

Guillain Barre syndrome, relapse

Guillain Barre syndrome, variant forms of

Gulf War syndrome

H1N1 influenza

hallucination

hallucination, auditory

hallucination, visual

head circumference

head injury

headache

headache, drug induced

headache, severe

headache, worst of life

heart block

heart valve surgery

heart valve, prosthetic

heart valve, repair

hematuria, microscopic

hemiplegia, progressive

heralding manifestation

herniation syndromes, intracranial

herpes encephalitis

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, recurrent

herpes simplex encephalitis, treatment of

herpes simplex virus

herpes simplex virus infection, immunosuppressed patient

herpes virus

herpes virus infection

herpes zoster

herpes zoster, ophthalmicus

herpes zoster, vaccine

highly active antiretroviral therapy

hippocampal atrophy

hippocampus

hippocampus, hyperintense

HIV-associated neurocognitive disorder

HMGcoA reductase inhibitors

Hodgkin's disease

Horner's syndrome

hospital length of stay

human herpesvirus 6

human immunodeficiency virus type 1

hydrocephalus

hydrocephalus, non-communicating(obstructive)

hydrocephalus, treatment of

hyperactivity

hyperammonemic encephalopathy

hypercoagulable state

hyperekplexia

hypersensitivity reaction

hypertension

hyperviscosity

hypocretin

hypogammaglobulinemia

hypoglycorrhachia

hyponatremia

hyporeflexia

hypotension, systemic

hypoxia

hypoxic encephalopathy

iatrogenic neurologic disorders

ibuprofen

idiopathic CD4+lymphopenia

idiopathic thrombocytopenic purpura

IgG4-related disease

immune checkpoint inhibitors

immune effector cell-associated neurotoxicity syndrome

immune reconstitution inflammatory syndrome

immune reconstitution inflammatory syndrome, paradoxical

immune reconstitution inflammatory syndrome, unmasked

immune-related adverse events

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

implantable cardioverter defibrillator

in situ hybridization

inborn errors of metabolism

incidence

inclusion body myositis

intellectual deterioration

internal carotid artery

internuclear ophthalmoplegia

intracardiac device

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial hypertension, benign

intracranial pressure, increased

intravenous drug abuse

intravenous line

ipilimumab

Jakob-Creutzfeldt disease

Janeway spots

JC virus

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

labor, complicated

leg weakness, bilateral

Legionella pneumophilia

lethargy

leucine rich glioma inactivated 1 antibodies

leukemia

leukemia, neurologic findings assoc.with

leukodystrophy

leukoencephalopathy

leukoencephalopathy, toxic

leukopenia

levamisole

level of consciousness, decreased

lid abnormalities

lid closure, weakness of

listeria monocytogenes

listeriosis, CNS

liver disease

liver function enzymes

liver transplantation

lymphoma involving CNS

lymphoma, plasmablastic

lymphoma, primary of CNS

medication withdrawal

melanoma, malignant

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, aspergillus

meningitis, bacterial

meningitis, bacterial, community acquired

meningitis, bacterial-negative CSF culture

meningitis, bacteriologic etiology of

meningitis, basilar

meningitis, candida

meningitis, chronic

meningitis, clinical features of

meningitis, CSF cell count-normal

meningitis, CSF findings in

meningitis, drug induced

meningitis, eosinophilic

meningitis, factors influencing mortality in

meningitis, fungal

meningitis, fungal-negative CSF culture

meningitis, granulomatous

meningitis, hemophilus influenza

meningitis, iatrogenic

meningitis, late neurologic sequelae in

meningitis, leukemic

meningitis, listeria monocytogenes

meningitis, meningococcal

meningitis, Mollaret's

meningitis, neurologic aspects and complications of

meningitis, neutrophilic

meningitis, neutrophilic, persistent

meningitis, newborn

meningitis, noninfectious

meningitis, pneumococcal

meningitis, predisposing factors in

meningitis, recurrent

meningitis, seizures with

meningitis, spinal fluid smear and culture of

meningitis, spinal fluid smear and culture-negative

meningitis, syphilitic

meningitis, TB

meningitis, treatment of

meningoencephalitis

meningoencephalitis, amoebic

meningoencephalopathy

mental status, abnormal

microabscesses, cerebral

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

middle cerebral artery, occlusion of

migraine

migraine, prophylaxis

mitral valve vegetation

molecular genetics

monoclonal antibodies

mononeuritis multiplex

mononeuropathy

mortality

movement disorder

movement disorder, drug induced

MRI

MRI, abnormal

MRI, angiography

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, high signal foci on

MRI, sulcal hyperintensity

MRS

multiple organ failure

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, aggressive

multiple sclerosis, chronic progressive

multiple sclerosis, diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, differential diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, misdiagnosis of

myasthenia gravis, neonatal

myasthenia gravis, ocular

myasthenia gravis, presenting manifestations

myasthenia gravis, prognosis of

myasthenia gravis, remission of

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, unmasked

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

mycobacterium avium-intracellulare

myelitis, transverse, recurrent

myopathy, drug-induced

myopathy, inflammatory

myopathy, necrotizing

myopathy, necrotizing, autoimmune

myopathy, necrotizing, immune-mediated

myopathy, steroid responsive

natalizumab, discontinuation

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurexin-3 alpha antibodies

neuroblastoma

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic education

neurologic signs

neurologic symptoms

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuronal cell surface antigen

neuroophthalmology

neuropathology

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

next-generation sequencing

nonsteroidal anti-inflammatory drug

normal

nystagmus

nystagmus, direction changing

nystagmus, primary position of gaze

ocular motility, disorders of

oculomasticatory myorhythmia

oculovestibular reflex

old age, neurology of

ophthalmoplegia

opportunistic infection

opportunistic infection, CNS

opsoclonus

opsoclonus, differential diagnosis of

optic disc edema

optic nerve, enhancement

optic neuritis

optic neuropathy

organ transplantation

otitis, neurologic complications with

outcome research

pacemaker, cardiac-transvenous

parasitic infection, CNS

peripheral blood stem cell transplantation

peripheral nerve, lesion of

personality change

photophobia

pituitary stalk

pituitary stalk, enlarged

plasmapheresis

plasmapheresis, complications of

pleocytosis of cerebrospinal fluid

pleurisy

pneumonia

poison, organophosphate

poliomyelitis

poliomyelitis vaccine

polycythemia, primary

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

pons, infarction of

pons, lesion of

post herpes simplex encephalitis immune-mediated relapse

post transplant lymphoproliferative disease

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

postoperative neurologic complications

potassium channel antibodies

practice guidelines

precipitating factors

pre-eclampsia

pregnancy, neurologic complications in

premature infant

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

pseudointernuclear ophthalmoplegia

psoriatic arthritis

psychiatric problems in neurologic disorders

pulmonary infiltrates

pupil, dilated and fixed, bilateral

radiation therapy, CNS treatment and complications with

radiation therapy, total body

Ramsay Hunt syndrome

rapidly fatal neurologic illness

rapidly progressing neurologic illness

rash

ravulizumab

reading disorder, acquired

remote effect of cancer on the nervous system

renal failure

renal failure, acute

renal transplantation

renal tubular necrosis

repetitive nerve stimulation

respirator

respiratory failure

respiratory tract infection

retinal lesion

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rhabdomyolysis

rheumatoid arthritis

rheumatoid arthritis factor(R.A.factor)

rhinorrhea, CSF

risk factors

risk stratification

risk-benefit assessment

rituximab

rozanolixizumab

saccadic eye movements

saccadic eye movements, abnormal

seizure, diagnosis of

seizure, drug resistance

seizure, drug-induced

seizure, non-treatment of

seizure, psychomotor-temporal lobe

seizure, psychosocial aspects of

seizure, surgical treatment of

seizure, systemic disease causing

seizure, treatment of

seizure, treatment of, first

seizure, workup of

septicemia

serologic testing

serologic testing, false negative

seronegative

seropositive

serum alanine aminotransferase

sex reassignment surgery

shared decision making

shunt procedure, ventricular

shunt procedure, ventricular-complications of

sickle cell disease

simultanagnosia

single-fiber electromyography

sinusitis

sirolimus

Sjogren's syndrome

skin, lesions in neurologic disorders

sleep

snout reflex

soap-bubble appearance

spinal cord, lesion of

splenomegaly

staphylococcal protein A column therapy

staphylococcus aureus

statin therapy

statin therapy, discontinuation

status epilepticus

stem cell transplantation

steroid

steroid sparing therapy

steroid therapy, CNS treatment and complications with

stiff man syndrome

stillbirth

streptococcus pneumoniae

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hemorrhage

subconjunctival hemorrhage

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

temporal lobe, lesion

temporal lobe, lesion, bilateral

tensilon

tensilon test, false negative

tensilon test, false positive

tensilon test, paradoxical

thalamus, lesion of-bilateral

tissue plasminogen activator, intravenous

tonsillar herniation of cerebellum

toxic encephalopathy

toxins, nervous system

transient epileptic amnesia

transient ischemic attack

transient neurologic deficit

treatment of neurologic disorder

tremor

tremulousness

trigeminal neuropathy

tuberculoma of CNS

tuberculosis

tumor necrosis factor inhibitor

urinary tract infection

urine, dark

vaccination, neurologic complications with

vaccine

vaccine-induced thrombocytopenia

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

venous thrombosis, non-cerebral

ventricular assist device

Virchow-Robin spaces, dilated

visual acuity, decreased

visual field defect

visual impairment

visual loss

visuospatial disturbance

vomiting, episodic

vomiting, recurrent

voriconazole

walking, difficulty with

war

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weakness, progressive

white matter disease, subcortical

wide based gait

word-finding difficulty

Showing articles 100 to 150 of 5507 << Previous Next >>

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
NEJM 365:1293-1303, OConnor, P.,et al, 2011

Whipple Limbic Encephalitis
Arch Neurol 68:1471-1473, Blanc, F.,et al, 2011

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Primary Varicella Zoster Infection Associated With Fingolimod Treatment
Neurol 76:1023-1024, Uccelli,A.,et al, 2011

Tumefactive Demyelination, an Uncommon Form of Tacrolimus Neurotoxicity
Neurol 76:672-674, Kim,S.H.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Efficacy and Safety of Mitoxantrone in Patients with Highly Relapsing Neuromyelitis Optica
Arch Neurol 68:473-479, Kim, S.H.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Comparison of IVIg and PLEX in patients with myasthenia gravis
Neurol 76:2017-2023, Barth, D.,et al, 2011

Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011

Progressive Multifocal Leukoencephalopathy: Prognosis and treatment
UpToDate, June, Koralnik, I.J.,et al, 2011

Analysis of Relapses in Anti-NMDAR Encephalitis
Neurol 77:996-999, Gabilondo, I.,et al, 2011

Narcolepsy Onset is Seasonal and Increased following the 2009 H1N1 Pandemic in China
Ann Neurol 70:410-417,A5, Han, F.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Headache in Transplant Patients
www.medlink.com, Aug, Lai, T.H., 2011

Toxoplasmic Encephalitis IRIS in HIV-Infected Patients
JNNP 82:691-693, Martin-Blondel, G.,et al, 2011

Comparative Analysis of Therapeutic Options Used for Myasthenia Gravis
Ann Neurol 68:797-805, Mandawat,A.,et al, 2010

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
NEJM 362:416-426, 456, Giovannoni,G.,et al, 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Is the Diagnosis at Hand?
The Lancet 375:1134, Holmes,M.V., et al, 2010

Open Biopsy in Patients With Acute Progressive Neurologic Decline and Absence of Mass Lesion
Neurol 75:419-424, Schuette,A.J., et al, 2010

An Effective Immunotherapy Regimen for VGKC Antibody-Positive Limbic Encephalitis
JNNP 81:1167-1169, Wong,S.H.,et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor- Inhibitors
CID 49:924-927, Bradford, R.D.,et al, 2009

Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy
JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Sirolimus-Induced Posterior Reversible Encephalopathy
Neurol 68:2039-2040, Bodkin,C.L. &Eidelman,B.H., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Mycophenolate Mofetil in Dermatomyositis: Is It Safe?
Neurol 66:1245-1247, Rowin,J.,et al, 2006

Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006

Immune Reconstitution Inflammatory Syndrome in the CNS of HIV Infected Patients
Neurol 67:383-388, Venkataramana,A.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

Immune Reconstitution Inflammatory Syndrome Associated with PML in AIDS: A Treatable Disorder
Neurol 67:1692-1694, Martinez,J.V.,et al, 2006

Spectrum and Prognosis of Neurologic Complications After Hematopoietic Transplantation
Neurol 67:1990-1997, Denier,C.,et al, 2006

Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006

Showing articles 100 to 150 of 5507 << Previous Next >>